Immuron Stock (NASDAQ: IMRN) stock price, news, charts, stock research, profile.
Open | $2.530 |
Close | $2.540 |
Volume / Avg. | 4.671K / 920.037K |
Day Range | 2.530 - 2.550 |
52 Wk Range | 1.481 - 5.960 |
Market Cap | $13.953M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 0 |
Short Interest | - |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Immuron (NASDAQ: IMRN) through any online brokerage.
Other companies in Immuron’s space includes: Vaxxinity (NASDAQ:VAXX), Dominari Holdings (NASDAQ:DOMH), Imunon (NASDAQ:IMNN), Monopar Therapeutics (NASDAQ:MNPR) and Coeptis Therapeutics (NASDAQ:COEP).
The latest price target for Immuron (NASDAQ: IMRN) was reported by HC Wainwright & Co. on Wednesday, October 18, 2017. The analyst firm set a price target for 15.00 expecting IMRN to rise to within 12 months (a possible 512.24% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Immuron (NASDAQ: IMRN) is $2.45 last updated April 29, 2024 at 6:34 PM EDT.
There are no upcoming dividends for Immuron.
Immuron’s H1 earnings are confirmed for Tuesday, May 14, 2024.
There is no upcoming split for Immuron.
Immuron is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.